Market Access in Healthcare
The challenges of market access in healthcare as seen by Digital Pharma Lab
Market access in the pharmaceutical sector is an essential step.
This is because it ensures that innovations in healthcare, be they drugs, medical devices or e-health solutions, are accessible to patients under the best possible conditions.
But the growing demands of regulators, payers and healthcare decision-makers can create friction.
And with this in mind, an optimized access strategy is essential to ensure appropriate reimbursement and efficient uptake, something our healthcare consultancy can guarantee.
Digital Pharma Lab's expertise: a customized market access strategy
Digital Pharma Lab helps healthcare companies define and manage their market access strategy.
We take into account economic, regulatory and clinical issues, and intervene at every stage of the process.
Market environment analysis
To help you understand the regulatory landscape, assess stakeholder expectations and identify unmet needs.
We define your market access strategy
By developing a reimbursement plan and a value proposition tailored to payers' requirements.
We structure reimbursement files and support you in negotiations
We participate in the drafting of arguments based on solid clinical and economic data. Then we interface with healthcare decision-makers to optimize access and pricing conditions.
Our methodology
Our methodology is based on in-depth analysis through an initial diagnosis and a strategy adapted to each project. Our consultants can be placed on site.
1. Analysis and positioning
We assess the key factors influencing an innovation's access to the market, taking into account the regulatory context, reimbursement models and the expectations of patients and healthcare professionals.
2. Structuring and submitting files
We help our customers to build convincing business cases that include a rigorous clinical and economic evaluation, essential for justifying the medical and economic benefits of their solution.
3. Pricing strategy and negotiation
We define the most appropriate pricing strategies and lead discussions with health authorities to obtain the best reimbursement conditions.
Our market access sector expertise is widely recognized
Our healthcare consultancy works with a wide variety of players in the pharma sector, including :
- Pharmaceutical and biotech industries
- Medical devices and in vitro diagnostics
- Startups in e-health
- Healthcare institutions and public decision-makers.
Digital Pharma Lab has also been chosen by EIT Health as a partner to support European biotech, healthtech and digital health startups in their market access strategy in France.
They trust us
Some customer references
With over 150 innovation projects supported
we support more than 40 healthcare players, from project design to deployment, in their innovation strategy and digital transformation.
Our mission is to create experiences where strategy, innovation and collaboration meet.
INTERNATIONAL DEPLOYMENT DTX
We support the collaboration between Sanofi's German subsidiary and startup ProCarement, which aims to improve the care of heart failure patients through a digital approach to care.
FAQ market access in healthcare
Answers to frequently asked questions
Are you ready to accelerate your market access strategy?
Contact us to define your approach and ensure the long-term success of your healthcare innovation.
"*" indicates required fields